Taspoglutide is a pharmaceutical drug, a glucagon-like peptide-1 agonist (GLP-1 agonist), under investigation for treatment of type 2 diabetes being codeveloped by Ipsen and Roche. In September 2010 Roche halted Phase III clinical trials due to incidences of serious hypersensitivity reactions and gastrointestinal side effects. As of May 2013 no new trials had been registered.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Pegvisomant | The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Taspoglutide. |
| Lipoic acid | The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Taspoglutide. |
| Moxifloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Moxifloxacin. |
| Grepafloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Grepafloxacin. |
| Enoxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Enoxacin. |
| Pefloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Pefloxacin. |
| Ciprofloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Ciprofloxacin. |
| Trovafloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Trovafloxacin. |
| Nalidixic acid | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Nalidixic acid. |
| Rosoxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Rosoxacin. |
| Cinoxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Cinoxacin. |
| Lomefloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Lomefloxacin. |
| Gatifloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Gatifloxacin. |
| Norfloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Norfloxacin. |
| Levofloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Levofloxacin. |
| Gemifloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Gemifloxacin. |
| Ofloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Ofloxacin. |
| Sparfloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Sparfloxacin. |
| Temafloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Temafloxacin. |
| Fleroxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Fleroxacin. |
| Technetium Tc-99m ciprofloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Technetium Tc-99m ciprofloxacin. |
| Garenoxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Garenoxacin. |
| Nemonoxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Nemonoxacin. |
| Flumequine | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Flumequine. |
| Enrofloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Enrofloxacin. |
| Orbifloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Orbifloxacin. |
| Sarafloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Sarafloxacin. |
| Difloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Difloxacin. |
| Pazufloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Pazufloxacin. |
| Prulifloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Prulifloxacin. |
| Delafloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Delafloxacin. |
| Sitafloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Sitafloxacin. |
| Oxolinic acid | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Oxolinic acid. |
| Rufloxacin | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Rufloxacin. |
| Pipemidic acid | The therapeutic efficacy of Taspoglutide can be increased when used in combination with Pipemidic acid. |
| Methyclothiazide | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Methyclothiazide. |
| Chlorthalidone | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Chlorthalidone. |
| Bendroflumethiazide | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Bendroflumethiazide. |
| Metolazone | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Metolazone. |
| Benzthiazide | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Benzthiazide. |
| Hydroflumethiazide | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Hydroflumethiazide. |
| Indapamide | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Indapamide. |
| Chlorothiazide | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Chlorothiazide. |
| Hydrochlorothiazide | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Hydrochlorothiazide. |
| Trichlormethiazide | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Trichlormethiazide. |
| Polythiazide | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Polythiazide. |
| Quinethazone | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Quinethazone. |
| Cyclopenthiazide | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Cyclopenthiazide. |
| Epitizide | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Epitizide. |
| Amitriptyline | Amitriptyline may decrease the hypoglycemic activities of Taspoglutide. |
| Protriptyline | Protriptyline may decrease the hypoglycemic activities of Taspoglutide. |
| Imipramine | Imipramine may decrease the hypoglycemic activities of Taspoglutide. |
| Nortriptyline | Nortriptyline may decrease the hypoglycemic activities of Taspoglutide. |
| Amoxapine | Amoxapine may decrease the hypoglycemic activities of Taspoglutide. |
| Trimipramine | Trimipramine may decrease the hypoglycemic activities of Taspoglutide. |
| Doxepin | Doxepin may decrease the hypoglycemic activities of Taspoglutide. |
| Desipramine | Desipramine may decrease the hypoglycemic activities of Taspoglutide. |
| Clomipramine | Clomipramine may decrease the hypoglycemic activities of Taspoglutide. |
| Amineptine | Amineptine may decrease the hypoglycemic activities of Taspoglutide. |
| Dimetacrine | Dimetacrine may decrease the hypoglycemic activities of Taspoglutide. |
| Butriptyline | Butriptyline may decrease the hypoglycemic activities of Taspoglutide. |
| Dosulepin | Dosulepin may decrease the hypoglycemic activities of Taspoglutide. |
| Tianeptine | Tianeptine may decrease the hypoglycemic activities of Taspoglutide. |
| Oxaprotiline | Oxaprotiline may decrease the hypoglycemic activities of Taspoglutide. |
| Opipramol | Opipramol may decrease the hypoglycemic activities of Taspoglutide. |
| Amitriptylinoxide | Amitriptylinoxide may decrease the hypoglycemic activities of Taspoglutide. |
| Dibenzepin | Dibenzepin may decrease the hypoglycemic activities of Taspoglutide. |
| Quinupramine | Quinupramine may decrease the hypoglycemic activities of Taspoglutide. |
| Melitracen | Melitracen may decrease the hypoglycemic activities of Taspoglutide. |
| Lofepramine | Lofepramine may decrease the hypoglycemic activities of Taspoglutide. |
| Iprindole | Iprindole may decrease the hypoglycemic activities of Taspoglutide. |
| Imipramine oxide | Imipramine oxide may decrease the hypoglycemic activities of Taspoglutide. |
| Glimepiride | Taspoglutide may increase the hypoglycemic activities of Glimepiride. |
| Acetohexamide | Taspoglutide may increase the hypoglycemic activities of Acetohexamide. |
| Chlorpropamide | Taspoglutide may increase the hypoglycemic activities of Chlorpropamide. |
| Tolazamide | Taspoglutide may increase the hypoglycemic activities of Tolazamide. |
| Glyburide | Taspoglutide may increase the hypoglycemic activities of Glyburide. |
| Glipizide | Taspoglutide may increase the hypoglycemic activities of Glipizide. |
| Gliclazide | Taspoglutide may increase the hypoglycemic activities of Gliclazide. |
| Tolbutamide | Taspoglutide may increase the hypoglycemic activities of Tolbutamide. |
| Gliquidone | Taspoglutide may increase the hypoglycemic activities of Gliquidone. |
| Glisoxepide | Taspoglutide may increase the hypoglycemic activities of Glisoxepide. |
| Glibornuride | Taspoglutide may increase the hypoglycemic activities of Glibornuride. |
| Carbutamide | Taspoglutide may increase the hypoglycemic activities of Carbutamide. |
| Metahexamide | Taspoglutide may increase the hypoglycemic activities of Metahexamide. |
| Dapagliflozin | Dapagliflozin may increase the hypoglycemic activities of Taspoglutide. |
| Canagliflozin | Canagliflozin may increase the hypoglycemic activities of Taspoglutide. |
| Leuprolide | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Leuprolide. |
| Goserelin | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Goserelin. |
| Nelfinavir | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Nelfinavir. |
| Indinavir | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Indinavir. |
| Ziprasidone | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Ziprasidone. |
| Etonogestrel | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Etonogestrel. |
| Desogestrel | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Desogestrel. |
| Olanzapine | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Olanzapine. |
| Megestrol acetate | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Megestrol acetate. |
| Clozapine | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Clozapine. |
| Levonorgestrel | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Levonorgestrel. |
| Progesterone | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Progesterone. |
| Chlorpromazine | The therapeutic efficacy of Taspoglutide can be decreased when used in combination with Chlorpromazine. |